Screener
Pelthos Therapeutics PTHS Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Pelthos Therapeutics’s reported figures.
The source filing: Pelthos Therapeutics’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001919246-26-000070
FAQ
- What is Pelthos Therapeutics's free cash flow?
- Pelthos Therapeutics (PTHS) reported free cash flow of -$13.32M in Q1 2026.
- How has Pelthos Therapeutics's free cash flow changed year-over-year?
- Pelthos Therapeutics's free cash flow decreased by 2007.6% year-over-year, from -$632K to -$13.32M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Pelthos Therapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude